CodeX Discovery employs the target specific virtual screening methodology and technology platform developed and validated over five years in the Molecular Design Group in Trinity College Dublin.
Utility of this technology in the context of commercially licensed drug design and visualisation software facilitates both scaffold hopping and depeptidisation by the company's experienced designers. Incorporation of robust bespoke computational ADMET filters such as propensity for Cytochrome P450 metabolism and blood-brain barrier penetration add significant value to the design cascade and process.
Scaffold Hopping is the technique of computationally moving from a known active molecular framework to a novel patentable framework with similar or improved properties and potencies.
Depeptidisation is the technique of computationally moving from peptide/non drug-like structures with biological activity to small drug-like novel chemical entities with preserved activity and additional ligand potential.